AKT1 and neoplasm: An increasing number of studies have demonstrated that the Akt-mTOR pathway controls autophagy induction, and anticancer agents can inhibit tumor survival and growth via suppression of the Akt-mTOR pathway along with stimulation of autophagy [46,47].